|
21 Mar 2019 |
Alexion and Affibody Announce Partnership to Co-Develop Anti-FcRn Affibody® Molecule
|
|
20 Mar 2019 |
Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics
|
|
20 Mar 2019 |
Domainex and SpiroChem Enter a Fragment Drug Discovery Partnership
|
|
20 Mar 2019 |
Alexion and Zealand Pharma Announce Collaboration to Discover and Develop Peptide Therapies for Complement-Mediated Diseases
|
|
19 Mar 2019 |
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD
|
|
19 Mar 2019 |
Ono Pharmaceutical and twoXAR Announce Drug Discovery Research Collaboration
|
|
14 Mar 2019 |
Merck KGaA, Darmstadt, Germany, Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology
|
|
13 Mar 2019 |
Seres Therapeutics Announces Microbiome Immuno-Oncology Focused Collaboration with AstraZeneca
|
|
13 Mar 2019 |
Flow Pharma, Inc. and OncoImmunity AS partner for the Development of FlowVaxTM Personalized Cancer Vaccines
|
|
13 Mar 2019 |
HitGen and SPARC Enter DNA-Encoded Library Based Innovative Drug Discovery Research Collaboration
|
|
11 Mar 2019 |
Parkinson’s disease: Servier and Oncodesign join forces to investigate new line of research
|
|
11 Mar 2019 |
Stemline In-Licenses Worldwide Rights to Novel Selective RET Inhibitor (SL-1001); Expands Oncology Pipeline
|
|
11 Mar 2019 |
Principia Biopharma Reacquires Rights to Oral Immunoproteasome Program
|
|
11 Mar 2019 |
aTyr Pharma Announces Research Collaboration With Global Biotherapeutics Leader CSL Behring
|
|
11 Mar 2019 |
Bridge Medicines Enters Agreement with Weill Cornell Medicine to Develop a Novel Sphingosine 1-Phosphate (S1P) Receptor Modulator
|
|
09 Mar 2019 |
TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with Newsoara Biopharma on JKB-122 Asian Rights
|
|
09 Mar 2019 |
Xencor Announces Closing of Research Collaboration and License Agreement with Genentech
|
|
06 Mar 2019 |
ReForm Biologics Announces Collaboration Agreement with Astellas Pharma Inc.
|
|
06 Mar 2019 |
AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes
|
|
06 Mar 2019 |
Glenmark Pharmaceuticals Announces Appointment of Alessandro Riva as CEO of its New Innovation Company
|
|
06 Mar 2019 |
Iksuda Therapeutics and Femtogenix sign license agreement
|
|
05 Mar 2019 |
Numab Announces Entry into a License Agreement With Intarcia for Anti-Inflammatory ND016
|
|
05 Mar 2019 |
Xenetic Biosciences, Inc. Announces Agreement to Acquire Innovative CAR T Technology Platform
|
|
04 Mar 2019 |
Adagene Announces a Platform Evaluation of the Dynamic Precision Library with Celgene Corporation
|
|
04 Mar 2019 |
NantKwest Signs Worldwide License Agreement with ProMab Biotechnologies to Exclusively Develop Select Next Generation Targeted Natural Killer Cell Therapeutics
|
